Pharmacist-led medication reviews in aged care residents with dementia: A systematic review.
aged care
dementia
medication therapy management
pharmacists
systematic review
Journal
Australasian journal on ageing
ISSN: 1741-6612
Titre abrégé: Australas J Ageing
Pays: Australia
ID NLM: 9808874
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
27
08
2019
revised:
26
05
2020
accepted:
27
05
2020
pubmed:
5
8
2020
medline:
25
6
2021
entrez:
5
8
2020
Statut:
ppublish
Résumé
To evaluate outcomes associated with pharmacist-led medication reviews in residential aged care facility (RACF) residents with dementia. Six scientific databases were searched. All study designs investigating pharmacist-led medication reviews in RACF residents with dementia were considered. The protocol was registered with PROSPERO (CRD42019121681). One randomised controlled trial (RCT) and five observational studies were identified. Two studies reported reductions in medication usage per resident, and one study reported improved appropriateness of psychotropic use following reviews as part of multi-faceted, collaborative interventions. In three studies, reviews undertaken as an isolated intervention or by a visiting pharmacist with minimal collaboration with physicians were associated with low implementation rates of recommendations to alter therapy. Pharmacist-led medication reviews, when conducted collaboratively, may improve the use of medicines in RACF residents with dementia. However, robust conclusions cannot be drawn, largely due to the low quality of evidence available, including only one RCT.
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e478-e489Informations de copyright
© 2020 AJA Inc.
Références
Hillen JB, Vitry A, Caughey GE. Medication-related quality of care in residential aged care: an Australian experience. Int J Qual Health Care. 2019;31(4):298-306.
Harrison SL, Kouladjian O’Donnell L, Milte R, et al. Costs of potentially inappropriate medication use in residential aged care facilities. BMC Geriatr. 2018;18(1):9.
Davies EA, O’Mahony MS. Adverse drug reactions in special populations - the elderly. Brit J Clin Pharmacol. 2015;80(4):796-807.
Roberts MS, Stokes JA, King MA, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Brit J Clin Pharmacol. 2001;51(3):257-265.
Elliott RA. Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res. 2006;36(1):58-66.
Hillen JB, Vitry A, Caughey GE. Evaluating medication-related quality of care in residential aged care: a systematic review. SpringerPlus. 2015;4(1):220.
Jokanovic N, Tan EC, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc. 2015;16(6):535.e1-535.e12.
Jokanovic N, Wang KN, Dooley MJ, et al. Prioritizing interventions to manage polypharmacy in Australian aged care facilities. Res Social Adm Pharm. 2016;13;564-574.
Leelakanok N, D'Cunha RR. Association between polypharmacy and dementia - a systematic review and metaanalysis. Aging Ment Health. 2019;23(8):932-941.
Vetrano DL, Tosato M, Colloca G, et al. Polypharmacy in nursing home residents with severe cognitive impairment: Results from the SHELTER Study. Alzheimers Dement. 2013;9(5):587-593.
Chhabra PT, Rattinger GB, Dutcher SK, Hare ME, Parsons KL, Zuckerman IH. Medication reconciliation during the transition to and from long-term care settings: a systematic review. Res Social Adm Pharm. 2012;8(1):60-75.
Tjia J, Lemay CA, Bonner A, et al. Informed family member involvement to improve the quality of dementia care in nursing homes. J Am Geriatr Soc. 2017;65(1):59-65.
Brownie S, Horstmanshof L. Creating the conditions for self-fulfilment for aged care residents. Nurs Ethics. 2012;19(6):777-786.
Burns E, Nair S. New horizons in care home medicine. Age Ageing. 2014;43(1):2-7.
Alldred DP, Kennedy M-C, Hughes C, Chen TF, Miller P. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2016;2(2):CD009095.
Howe AL, King DS, Ellis JM, Wells YD, Wei Z, Teshuva KA. Stabilising the aged care workforce: an analysis of worker retention and intention. Aust Health Rev. 2012;36(1):83-91.
Phillips J, Davidson PM, Jackson D, Kristjanson L, Daly J, Curran J. Residential aged care: the last frontier for palliative care. J Adv Nursing. 2006;55(4):416-424.
King D, Mavromaras K, He B, Healy J, Macaitis K, Moskos M, et al. The aged care workforce 2012: final report. 2013. https://agedcare.health.gov.au/sites/default/files/documents/11_2014/rdp004-nacwcas-report.pdf. Accessed May 3, 2019
Pfister B, Jonsson J, Gustafsson M. Drug-related problems and medication reviews among old people with dementia. BMC Pharmacol Toxicol. 2017;18(1):52.
Disalvo D, Luckett T, Agar M, Bennett A, Davidson PM. Systems to identify potentially inappropriate prescribing in people with advanced dementia: a systematic review. BMC Geriatr. 2016;16:114.
Eshetie TC, Nguyen TA, Gillam MH, Kalisch Ellett LM. A narrative review of problems with medicines use in people with dementia. Expert Opin Drug Saf. 2018;17(8):825-836.
Page AT, Potter K, Clifford R, McLachlan AJ, Etherton-Beer C. Medication appropriateness tool for co-morbid health conditions in dementia: consensus recommendations from a multidisciplinary expert panel. Intern Med J. 2016;46(10):1189-1197.
Reeve E, Trenaman SC, Rockwood K, Hilmer SN. Pharmacokinetic and pharmacodynamic alterations in older people with dementia. Expert Opin Drug Metab Toxicol. 2017;13(6):651-668.
Maidment ID, Fox C, Boustani M, Katona C. Medication management-the missing link in dementia interventions. Int J Geriatr Psychiatry. 2012;27(5):439-442.
Nygaard HA, Jarland M. Are nursing home patients with dementia diagnosis at increased risk for inadequate pain treatment? Int J Geriatr Psychiatry. 2005;20(8):730-737.
Gnjidic D, Agogo GO, Ramsey CM, Moga DC, Allore H. The impact of dementia diagnosis on patterns of potentially inappropriate medication use among older adults. J Gerontol A. 2018;73(10):1410-1417.
Tjia J, Briesacher BA, Peterson D, Liu Q, Andrade SE, Mitchell SL. Use of medications of questionable benefit in advanced dementia. JAMA Intern Med. 2014;174(11):1763-1771.
Child A, Clarke A, Fox C, Maidment I. A pharmacy led program to review antipsychotic prescribing for people with dementia. BMC Psychiatry. 2012;12(1):155.
Liu E, Dyer SM, Whitehead C, et al. Patterns of medication prescription by dementia diagnosis in Australian nursing home residents: a cross-sectional study. J Pharm Pract Res. 2019;49:33-40.
Harrison SL, Bradley C, Milte R, et al. Psychotropic medications in older people in residential care facilities and associations with quality of life: a cross-sectional study. BMC Geriatr. 2018;18(1):60.
Chen TF. Pharmacist-led home medicines review and residential medication management review: the Australian model. Drugs Ageing. 2016;33(3):199-204.
Sluggett JK, Ilomäki J, Seaman KL, Corlis M, Bell JS. Medication management policy, practice and research in Australian residential aged care: Current and future directions. Pharmacol Res. 2017;116:20-28.
Pharmaceutical Society of Australia. Guidelines for Pharmacists Providing Residential Medication Management Review (RMMR) and Quality Use of Medicines (QUM) Services [Internet]. Canberra: Pharmaceutical Society of Australia; 2011. https://my.psa.org.au/s/article/Guidelines-for-pharmacists-providing-RMMR. Accessed October 15, 2019
Jokanovic N, Tan ECK, Van den Bosch D, Kirkpatrick CM, Dooley MJ, Bell JS. Clinical medication review in Australia: a systematic review. Res Social Adm Pharm. 2016;12(3):384-418.
Hatah E, Braund R, Tordoff J, Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Brit J Clin Pharmacol. 2014;77(1):102-115.
Thiruchelvam K, Hasan SS, Wong PS, Kairuz T. Residential aged care medication review to improve the quality of medication use: a systematic review. J Am Med Dir Assoc. 2017;18(1);87.e1-87.e14.
Wallerstedt SM, Kindblom JM, Nylén K, Samuelsson O, Strandell A. Medication reviews for nursing home residents to reduce mortality and hospitalization: systematic review and meta-analysis. Br J Clin Pharmacol. 2014;78(3):488-497.
Forsetlund L, Eike MC, Gjerberg E, Vist GE. Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr. 2011;11:16-34.
Loganathan M, Singh S, Franklin BD, Bottle A, Majeed A. Interventions to optimise prescribing in care homes: systematic review. Age Ageing. 2011;40:150-162.
Verrue CLR, Petrovic M, Mehuys E, Remon JP, Vander Stichele R. Pharmacists’ interventions for optimization of medication use in nursing homes. Drugs Ageing. 2009;26(1):37-49.
Thompson Coon J, Abbott R, Rogers M, et al. Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review. J Am Med Dir Assoc. 2014;15(10):706-718.
Kroger E, Wilchesky M, Marcotte M, et al. Medication use among nursing home residents with severe dementia: identifying categories of appropriateness and elements of a successful intervention. J Am Med Dir Assoc. 2015;16(7):629.e1-629.e17.
Disalvo D, Luckett T, Bennett A, Davidson P, Agar M. Pharmacists’ perspectives on medication reviews for long-term care residents with advanced dementia: a qualitative study. Int. J Clin Pharm. 2019;41:950-962.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine. 2009;6:e1000100.
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377-384.
Kennelly J. Methodological approach to assessing the evidence. In Reducing Racial/Ethnic Disparities in Reproductive and Perinatal Outcomes. Boston, MA: Springer; 2011;7-19.
van der Spek K, Koopmans R, Smalbrugge M, et al. The effect of biannual medication reviews on the appropriateness of psychotropic drug use for neuropsychiatric symptoms in patients with dementia: a randomised controlled trial. Age Ageing. 2018;47(3):430-437.
Andrew MK, Bowles SK, Purcell CA, Marshall EG, Varatharasan N, Clarke B. Polypharmacy and use of potentially inappropriate medications in long-term care facilities: does coordinated primary care make a difference? Int J Pharm Pract. 2018;26(4):318-324.
Bach LL, Lazzaretto DL, Young CF, Lofholm PW. Improving nursing home compliance via revised antipsychotic use survey tool. Consult Pharm. 2017;32(4):228-238.
Maidment ID, Damery S, Campbell N, et al. Medication review plus person-centred care: a feasibility study of a pharmacy-health psychology dual intervention to improve care for people living with dementia. BMC Psychiatry. 2018;18(1):340-351.
Tang MM, Wollsen MG, Aagaard L. Pain monitoring and medication assessment in elderly nursing home residents with dementia. J Res Pharm Pract. 2016;5(2):126-131.
Wilchesky M, Mueller G, Morin M, et al. The OptimaMed intervention to reduce inappropriate medications in nursing home residents with severe dementia: results from a quasi-experimental feasibility pilot study. BMC Geriatr. 2018;18(1):204.
Kwint HF, Bermingham L, Faber A, Gussekloo J, Bouvy ML. The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review. Drugs Aging. 2013;30(2):91-102.
Petrovic M, Somers A, Onder G. Optimization of geriatric pharmacotherapy: role of multifaceted cooperation in the hospital setting. Drugs Aging. 2016;33(3):179-188.
Tong EY, Mitra B, Yip G, et al. Multi-site evaluation of partnered pharmacist medication charting and in-hospital length of stay. Brit J Clin Pharmacol. 2020;86(2):285-290.
Westaway K, Sluggett J, Alderman C, Moffat A, Procter N, Roughead E. The extent of antipsychotic use in Australian residential aged care facilities and interventions shown to be effective in reducing antipsychotic use: a literature review. Dementia. 2020;19:1189-1202.
Westbury J, Jackson S, Gee P, Peterson G. An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatr. 2009;22(1):26-36.
Westbury J, Tichelaar L, Peterson G, Gee P, Jackson S. A 12-month follow-up study of "RedUSe": a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. Int Psychogeriatr. 2011;23(8):1260-1269.
Westbury JL, Gee P, Ling T, et al. RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Med J Aust. 2018;208(9):398-403.
Vida S, Monette J, Wilchesky M, et al. A long-term care center interdisciplinary education program for antipsychotic use in dementia: program update five years later. Int Psychogeriatr. 2012;24(4):599-605.